ResMed Inc (RMD)

Industry Medical Instruments & Supplies

This stock can be held in an Investment ISA and an Investment Account

Sell

$222.78

Buy

$262.00

arrow-down$-2.40 (-0.95%)

Prices updated at 27 Oct 2026, 23:30 EDT

Prices minimum 15 mins delay

Prices in USD

ResMed makes continuous positive airway pressure devices and the masks used to treat obstructive sleep apnea, a condition in which the airway repeatedly collapses during sleep. Devices make up about half of revenue, masks and accessories close to 40%, ...

S&P 500

0.6%

NYSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

our Investment Fees and Charges.

Income statement

Year chevron-l-regular chevron-r-regular	2025	2026
	5,146m	5,653m
	3,055m	3,452m
	1,685m	1,908m
	32.75	33.76
	1,401m	1,523m
	1,921m	2,153m
Sales, General and administrative	993m	1,120m
Interest expenses	-	-
Provision for income taxes	277m	396m
Operating expenses	1,370m	1,543m
Income before taxes	1,678m	1,919m
Net income available to common shareholders	1,401m	1,523m
	9.55	10.47
Net interest income	4m	50m
Advertising and promotion	-	-
Net investment income, net	-	-
Realised capital gains (losses), net	-	-
Total benefits, claims and expenses	-	-
Earnings per share (diluted)	9.51	10.43
Free cash flow per share	11.936	11.1511
Book value/share	42.0238	46.8247
Debt equity ratio	0.135963	0.081518

Balance sheet

Year chevron-l-regular chevron-r-regular	2025	2026
Current assets	3,506m	4,325m
Current liabilities	1,019m	1,395m
Total capital	6,626m	6,985m
Total debt	852m	826m
Total equity	5,968m	6,585m
Total non current liabilities	-	-
Loans	658m	399m
Total assets	8,174m	8,966m
Total liabilities	-	-
Cash and cash equivalents	1,209m	1,469m
Common stock	146m	144m

Cash flow

Year chevron-l-regular chevron-r-regular	2025	2026
Cash at beginning of period	238m	1,209m
Cash dividends paid	-311m	-350m
	1,651m	1,629m
Investments (gains) losses	-200m	-545m
	1,209m	1,469m
Net income	-	-
	1,752m	1,806m
	-101m	-177m

The figures shown in the tables are quoted in the currency of the stock selected.

Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser.

© Copyright 2026 Morningstar. All rights reserved. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.

The ESG-related information, methodologies, tools, ratings, data and opinions contained or reflected herein are not directed to or intended for use or distribution to India-based clients or users and their distribution to Indian resident individuals or entities is not permitted, and Morningstar accepts no responsibility or liability whatsoever for the actions of third parties in this respect.